Boston Scientific (BSX) Land & Improvements (2025 - 2026)
Boston Scientific (BSX) reported Land & Improvements of $188.0 million for Q1 2026, up 8.67% sequentially from $173.0 million in Q4 2025.
Boston Scientific (BSX) Land & Improvements (2025 - 2026) Analysis & Trends
Boston Scientific (BSX) has 2 years of Land & Improvements data on file, last reported at $188.0 million in Q1 2026.
- For the quarter ending Q1 2026, Land & Improvements changed N/A year-over-year to $188.0 million; the trailing twelve-month figure through Mar 2026 stood at $188.0 million (changed N/A YoY), and the FY2025 full-year result was $173.0 million, changed N/A from the prior year.
- Land & Improvements improved to $188.0 million in Q1 2026, from $173.0 million in the prior quarter.
- In the past five years, Land & Improvements ranged from a high of $188.0 million in Q1 2026 to a low of $173.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Land & Improvements (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 1.80 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 188.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 112.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 188.00 Mn |
| Dec 31, 2025 | 173.00 Mn |